NAGE ChromaDex: Company Value to Revenue

The EV/Sales chart illustrates the business value-to-revenue dynamics, where the 659.66 mark indicates the current state. Growth in Niagen sales and the expansion of partnerships within the dietary supplement sector are driving the current momentum for Chromadex Corp (NAGE). Simultaneously, the company is implementing ESG standards by minimizing plastic use and conserving resources. Supply chain stability is ensured through in-house laboratories and rigorous quality control of precision components.
NAGE (ChromaDex Corp): analytical breakdowns and indicator data

This ratio determines the market value of the business relative to sales volume, excluding the impact of debt load. The calculation combines market capitalization and net debt, allowing for an assessment of the real price per unit of revenue. By analyzing the EV/Sales history, an investor identifies whether an asset is overvalued or possesses growth potential. For Chromadex Corp (NAGE), this is critical when scaling Niagen sales through global partners. The metric demonstrates how much the market is willing to pay for the company's leadership in the NAD+ booster segment.